QuickStats: Prevalence of High Total Cholesterol* Among Adults Aged ≥20 Years, by Age Group and Sex — National Health and Nutrition Examination Survey, 2015–2018

Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

The figure is a bar chart showing the prevalence of high total cholesterol among adults aged ≥20 years during 2015–2018, by age group and sex, according to the National Health and Nutrition Examination Survey. During 2015–2018, the prevalence of high total cholesterol among adults aged ≥20 years was 11.4%26#37;, with no significant difference between men (10.5%26#37;) and women (12.1%26#37;). Prevalence was highest among adults aged 40–59 years (15.7%26#37;), followed by those aged ≥60 years (11.4%26#37;), and lowest among those aged 20–39 years (7.5%26#37;). Among men, the prevalence was highest among those aged 40–59 years (14.5%26#37;), followed by those aged 20–39 years (9.5%26#37;), and lowest among those aged ≥60 years (6.0%26#37;). Among women, the pattern was different, with women aged 20–39 years (5.5%26#37;) having a lower prevalence than either women aged 40–59 years (16.9%26#37;) or women aged ≥60 years (15.9%26#37;). Prevalence among women aged 20–39 years was lower than that among men in this age group, but prevalence was higher among women aged ≥60 years than it was among men of that age group. There was no significant difference between men and women for adults aged 40–59 years.

* Defined as serum total cholesterol ≥240 mg/dL.

Estimates for the category of persons aged ≥20 years were age-adjusted by the direct method to the year 2000 U.S. Census population using the age groups 20–39, 40–59 and ≥60 years. Estimates are presented with 95% confidence intervals indicated by error bars.

During 2015–2018, the prevalence of high total cholesterol among adults aged ≥20 years was 11.4%, with no significant difference between men (10.5%) and women (12.1%). Prevalence was highest among adults aged 40–59 years (15.7%), followed by those aged ≥60 years (11.4%), and lowest among those aged 20–39 years (7.5%). Among men, the prevalence was highest among those aged 40–59 years (14.5%), followed by those aged 20–39 years (9.5%), and lowest among those aged ≥60 years (6.0%). Among women, the pattern was different, with women aged 20–39 years (5.5%) having a lower prevalence than either women aged 40–59 years (16.9%) or women aged ≥60 years (15.9%). Prevalence among women aged 20–39 years was lower than that among men in this age group, but prevalence was higher among women aged ≥60 years than it was among men of that age group. There was no significant difference between men and women for adults aged 40–59 years.

Sources: Carroll MD, Fryar CD. Total and high-density lipoprotein cholesterol in adults: United States, 2015–2018. NCHS Data Brief, no 363. https://www.cdc.gov/nchs/products/databriefs/db363.htm. National Center for Health Statistics, National Health and Nutrition Examination Survey, 2015–2018. https://www.cdc.gov/nchs/nhanes.htm.

Reported by: Margaret D. Carroll, MSPH, mdc3@cdc.gov, 301-458-4136; Craig M. Hales, MD.


Suggested citation for this article: QuickStats: Prevalence of High Total Cholesterol Among Adults Aged ≥20 Years, by Age Group and Sex — National Health and Nutrition Examination Survey, 2015–2018. MMWR Morb Mortal Wkly Rep 2020;69:690. DOI: http://dx.doi.org/10.15585/mmwr.mm6922a5.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [76K]